These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
735 related items for PubMed ID: 17336273
1. Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease. Ye M, Wang XJ, Zhang YH, Lu GQ, Liang L, Xu JY, Chen SD. Brain Res; 2007 Apr 20; 1142():206-16. PubMed ID: 17336273 [Abstract] [Full Text] [Related]
2. Dopaminergic neuroprotection by neurturin-expressing c17.2 neural stem cells in a rat model of Parkinson's disease. Liu WG, Lu GQ, Li B, Chen SD. Parkinsonism Relat Disord; 2007 Mar 20; 13(2):77-88. PubMed ID: 16963309 [Abstract] [Full Text] [Related]
3. [Adenovirus mediated vascular endothelial growth factor gene transfer protects dopaminergic neurons in Parkinson's disease: experiment with rats]. Tian YY, Sun SG, Wang JN, Tang CJ, Feng Y, Wang L, Chen XW, Qiao X. Zhonghua Yi Xue Za Zhi; 2006 Aug 08; 86(29):2054-9. PubMed ID: 17064552 [Abstract] [Full Text] [Related]
4. [Alternation of proteins in brain of Parkinson's disease model rats after the transplantation of TH-NTN gene modified bone marrow mesenchymal stem cells]. Huang Y, Chang C, Zhang JW, Gao XQ. Zhonghua Yi Xue Za Zhi; 2012 Sep 04; 92(33):2353-6. PubMed ID: 23158567 [Abstract] [Full Text] [Related]
5. Efficacy of Tyrosine Hydroxylase gene modified neural stem cells derived from bone marrow on Parkinson's disease--a rat model study. Zou Z, Jiang X, Zhang W, Zhou Y, Ke Y, Zhang S, Xu R. Brain Res; 2010 Jul 30; 1346():279-86. PubMed ID: 20570658 [Abstract] [Full Text] [Related]
6. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease. Chaturvedi RK, Shukla S, Seth K, Agrawal AK. Neurosci Lett; 2006 May 01; 398(1-2):44-9. PubMed ID: 16423459 [Abstract] [Full Text] [Related]
7. Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct. Fjord-Larsen L, Johansen JL, Kusk P, Tornøe J, Grønborg M, Rosenblad C, Wahlberg LU. Exp Neurol; 2005 Sep 01; 195(1):49-60. PubMed ID: 15919076 [Abstract] [Full Text] [Related]
10. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease. Zheng JS, Tang LL, Zheng SS, Zhan RY, Zhou YQ, Goudreau J, Kaufman D, Chen AF. Brain Res Mol Brain Res; 2005 Mar 24; 134(1):155-61. PubMed ID: 15790539 [Abstract] [Full Text] [Related]
11. Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease. Lu L, Zhao C, Liu Y, Sun X, Duan C, Ji M, Zhao H, Xu Q, Yang H. Brain Res Brain Res Protoc; 2005 May 24; 15(1):46-51. PubMed ID: 15878150 [Abstract] [Full Text] [Related]
18. Effects of engrafted neural stem cells derived from GFP transgenic mice in Parkinson's diseases rats. Wei P, Liu J, Zhou HL, Han ZT, Wu QY, Pang JX, Liu S, Wang TH. Neurosci Lett; 2007 May 23; 419(1):49-54. PubMed ID: 17420097 [Abstract] [Full Text] [Related]
20. Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors. Glavaski-Joksimovic A, Virag T, Chang QA, West NC, Mangatu TA, McGrogan MP, Dugich-Djordjevic M, Bohn MC. Cell Transplant; 2009 May 23; 18(7):801-14. PubMed ID: 19796495 [Abstract] [Full Text] [Related] Page: [Next] [New Search]